研究発表 - 大家　基嗣

The change of serum C-reactive protein levels during molecular-targeted treatments could predict the response to anti-PD-1 treatment in metastatic renal cell carcinoma patients

Takamatsu K, Mizuno R, Hayakawa N, Tanaka N, Kosaka T, Kikuchi E, Oya M

ASCO Annual Meeting, 

2020年06月

A pooled analysis of the efficacy and safety of cabozantinib post immunotherapy in patients with advanced renal cell carcinoma

Oya M, Tamada S, Tatsugami K, Nakaigawa N, Osawa T, Kanayama H, Kondoh C, Sassa N, Nishimura K, Nozawa M, Masumori N, Miyoshi Y, Kimura A, Kuroda S, Motzer RJ, Choueiri TK, Tomita Y

ASCO Annual Meeting, 

2020年06月

The prognostic biomarkers of the patients treated with platinum-based chemotherapy in treatment emergent or related neuroendocrine prostate cancer

Kosaka T, Hongo H, Yasumizu Y, Matshumoto K, Mizuno R, Oya M

ASCO Annual Meeting, 

2020年06月

Predictors of first line systemic therapy for metastatic renal cell carcinoma in IMDC favorable risk patients

Mizuno R, Takamatsu K, Tanaka N, Hayakawa N, Kosaka T, Kikuchi E, Oya M

ASCO Annual Meeting, 

2020年06月

骨盤底筋過緊張に伴う排尿障害を来した先天性H型直腸尿道瘻の1例

浅沼　宏、高橋遼平、安水洋太、田中伸之、武田利和、森田伸也、松本一宏、小坂威雄、水野隆一、黒田達夫、大家基嗣

第34回日本小児ストーマ・排泄・創傷管理研究会, 

2020年06月

The change of serum C-reactive protein levels during molecular-targeted treatments could predict the response to anti-PD-1 treatment in metastatic renal cell carcinoma patients.

Kimiharu Takamatsu, Ryuichi Mizuno, Nozomi Hayakawa, Nobuyuki Tanaka, Takeo Kosaka, Eiji Kikuchi, Mototsugu Oya

American Society of Clinical Oncology Annual meeting, 

2020年06月

Role for the ectonucleotidase CD39: Outcome and association with PD-1/PD-L1 based cancer immunity in clear cell renal cell carcinoma

Tetsushi Murakami, Nobuyuki Tanaka, Kyohei Hakozaki, Kimiharu Takamatsu, Shuji Mikami, Youta Yasumizu, Toshikazu Takeda, Kazuhiro Matsumoto, Shinya Morita, Takeo Kosaka, Hiroshi Asanmua, Ryuichi Mizuno, Mototsugu Oya

AUA Annual Meeting, 

2020年05月

UNCOVERING INTRA-TUMOR AXL EXPRESSION HETEROGENEITY AND OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA: COMPREHENSIVE ANALYSIS FOR PRIMARY AND METASTATIC LESION

Kyohei Hakozaki, Nobuyuki Tanaka, Kimiharu Takamatsu, Shuji Mikami, Yota Yasumizu, Toshikazu Takeda, Kazuhiro Matsumoto, Shinya Morita, Takeo Kosaka, Hiroshi Asanuma, Ryuichi Mizuno, Mototsugu Oya

American Urological Association Annual Meeting, 

2020年05月

What timing is appropriate for a biochemical evaluation after laparoscopic adrenalectomy for unilateral aldosterone-producing adenoma?

Kimiharu Takamatsu, Toshikazu Takeda, Yota Yasumizu, Nobuyuki Tanaka, Shinya Morita, Kazuhiro Matsumoto, Takeo Kosaka, Ryuichi Mizuno, Hiroshi Asanuma, Isao Kurihara, Hiroshi Itoh, Mototsugu Oya

AUA Annual Meeting, 

2020年05月

Novel prognostification model for clear cell renal cell carcinoma: Proposing the immune-based clustering algorithm using future immune-checkpoint targets

Kimiharu Takamatsu, Nobuyuki Tanaka, Yota Yasumizu,Toshikazu Takeda , Shinya Morita, Kazuhiro Matsumoto, Takeo Kosaka, Ryuichi Mizuno, Hiroshi Asanuma, Isao Kurihara, Hiroshi Itoh, Mototsugu Oya

AUA Annual Meeting, 

2020年05月

Predicting the risk factors for muscle-invasive intravesical tumors that subsequently progressed from upper-tract urothelial carcinoma: Results of a multi-center cohort study

Shigeta K, Matsumoto K, Yasumizu Y, Tanaka N, Takeda T, Morita S, Kosaka T, Mizuno R, Kikuchi E, Asanuma H, Oya M

35th EAU Annual Congress, 

2020年03月

Gemcitabine Resistant Urothelial Cancer Cell may Acquire Cross Resistance to Cisplatin via Intracelluar Metabolic Reprogramming

Shigeta K, Kikuchi E, Hasegawa M, Matsumoto K, Kosaka T, Mizuno R, Mikami S, Oya M

35th EAU Annual Congress, 

2020年03月

Evaluating the clinical efficacy of neoadjuvant chemotherapy for node-positive upper tract urothelial carcinoma: A multi-center cohort study

Shigeta K, Matsumoto K, Yasumizu Y, Tanaka N, Takeda T, Morita S, Kosaka T, Mizuno R, Kikuchi E, Asanuma H, Oya M

35th EAU Annual Congress, 

2020年03月

Urothelial carcinoma cancer cells acquires cisplatin resistance via muc1-c oncoprotein regulation

Shigeta K, Kikuchi E, Hasegawa M, Matsumoto K, Kosaka T, Mizuno R, Mikami S, Kufe D, Miyajima A, Oya M

35th EAU Annual Congress, 

2020年03月

Comparing the oncological outcomes between pure laparoscopic radical nephroureterectomy and laparoscopic assisted nephroureterectomy for upper-tract urothelial carcinoma: A multi-center cohort study adjusted by propensity score matching

Shigeta K, Matsumoto K, Yasumizu Y, Tanaka N, Takeda T, Morita S, Kosaka T, Mizuno R, Kikuchi E, Asanuma H, Oya M

35th EAU Annual Congress, 

2020年03月

Treatment-free survival after discontinuation of immuno-checkpoint therapy, and outcome of subsequent molecular targeted therapy: Retrospective study of Japanese metastatic renal cell carcinoma patients (after I-O study)

Tomita Y, Kimura G, Fukasawa S, Sugiyama Y, Numakura K, Yamana K, Naito S, Kabu K, Tajima Y, Oya M

Genitourinary Cancers Symposium, 

2020年02月

エベロリムス導入後CMVハイリスク生体腎移植についての検討

高橋遼平、森田伸也、北岡壮太郎、環聡、田中伸之、武田利和、松本一宏、小坂威雄、篠田和伸、香野日高、水野隆一、浅沼宏、中川健、大家基嗣

第53回臨床腎移植学会, 

2020年02月

当院におけるマージナルドナーからの腎移植の検討

森田 伸也、高橋 遼平、環 聡、 松本 一宏、篠田 和伸、香野 日高、吉田 理、浅沼 宏、中川 健、大家 基嗣

第53回日本臨床腎移植学会, 

2020年02月

前立腺癌神経内分泌分化におけるMUC1の働き

安水　洋太、小坂　威雄、本郷　周、Hasan Rajabi、Caining Jin、Donald Kufe、大家　基嗣

第20回関東ホルモンと癌研究会, 

2020年01月

局所進行性前立腺癌の予後因子の検討

楊井祥典、小坂威雄、本郷 周、安水洋太、田中伸之、松本一宏、森田伸也、武田利和、三上修治、水野隆一、大家基嗣

第35回前立腺シンポジウム, 

2019年12月